Paul Hartmann AG Cash Flow Conversion Efficiency

Latest as of June 2023: 0.023x

Paul Hartmann AG cash flow conversion efficiency. Based on the latest financial reports, Paul Hartmann AG (PHH2) has a cash flow conversion efficiency ratio of 0.023x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€25.54 Million ≈ $29.86 Million USD) by net assets (€1.10 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Paul Hartmann AG (2013–2025)

Cash flow conversion efficiency of Paul Hartmann AG from 2013 to 2025. This chart illustrates how Paul Hartmann AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Paul Hartmann AG stock price today for real-time trading data and today's change.

Paul Hartmann AG Cash Flow Conversion Ratio Explained

Paul Hartmann AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Paul Hartmann AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Paul Hartmann AG ranked by their cash flow conversion efficiency. Also see PHH2 company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
PSI Software AG
F:PSAN
-0.030x
Foosung
KO:093370
-0.023x
INDIA SHELTER FINANCE CORPORATION LIMITED
NSE:INDIASHLTR
-0.149x
Iat Automobile Technology Co Ltd
SHE:300825
0.020x
Ningbo Thermal Power Co Ltd
SHG:600982
0.071x
Cicor Technologies Ltd
SW:CICN
0.104x
D I Corp
KO:003160
-0.065x
Jiangsu Pacific Precision
SHE:300258
0.029x

Annual Cash Flow Conversion Efficiency for Paul Hartmann AG (2013–2025)

The table below shows the annual cash flow conversion efficiency of Paul Hartmann AG from 2013 to 2025. Review cash generation quality of Paul Hartmann AG to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.22 Billion
≈ $1.43 Billion
€154.85 Million
≈ $181.04 Million
0.127x -23.73%
2024-12-31 €1.20 Billion
≈ $1.40 Billion
€198.66 Million
≈ $232.26 Million
0.166x -19.71%
2023-12-31 €1.12 Billion
≈ $1.30 Billion
€230.78 Million
≈ $269.81 Million
0.207x +22638.46%
2022-12-31 €1.13 Billion
≈ $1.32 Billion
€-1.04 Million
≈ $-1.21 Million
-0.001x -100.77%
2021-12-31 €1.09 Billion
≈ $1.28 Billion
€130.60 Million
≈ $152.69 Million
0.119x -61.86%
2020-12-31 €973.33 Million
≈ $1.14 Billion
€304.94 Million
≈ $356.50 Million
0.313x +81.14%
2019-12-31 €932.40 Million
≈ $1.09 Billion
€161.26 Million
≈ $188.53 Million
0.173x +8.28%
2018-12-31 €923.15 Million
≈ $1.08 Billion
€147.46 Million
≈ $172.39 Million
0.160x -31.90%
2017-12-31 €854.84 Million
≈ $999.40 Million
€200.51 Million
≈ $234.41 Million
0.235x +26.80%
2016-12-31 €816.21 Million
≈ $954.23 Million
€150.99 Million
≈ $176.52 Million
0.185x +2.64%
2015-12-31 €759.10 Million
≈ $887.47 Million
€136.81 Million
≈ $159.95 Million
0.180x -27.02%
2014-12-31 €690.37 Million
≈ $807.12 Million
€170.48 Million
≈ $199.31 Million
0.247x +36.83%
2013-12-31 €647.04 Million
≈ $756.46 Million
€116.78 Million
≈ $136.52 Million
0.180x --

About Paul Hartmann AG

F:PHH2 Germany Medical Instruments & Supplies
Market Cap
$782.72 Million
€669.50 Million EUR
Market Cap Rank
#10008 Global
#1218 in Germany
Share Price
€188.50
Change (1 day)
+0.27%
52-Week Range
€187.50 - €232.00
All Time High
€376.24
About

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management p… Read more